Pharma & Healthcare
Global Biological Excipient Market Research Report 2025
- Mar 11, 25
- ID: 32012
- Pages: 100
- Figures: 102
- Views: 13
The global market for Biological Excipient was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market"s growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients" effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
North American market for Biological Excipient is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biological Excipient is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biological Excipient include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG., Merck KGaA, Colorcon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biological Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Excipient.
The Biological Excipient market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biological Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biological Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market"s growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients" effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
North American market for Biological Excipient is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biological Excipient is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biological Excipient include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG., Merck KGaA, Colorcon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biological Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Excipient.
The Biological Excipient market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biological Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biological Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Biological Excipient Market Overview
1.1 Product Definition
1.2 Biological Excipient by Type
1.2.1 Global Biological Excipient Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Topical
1.3 Biological Excipient by Application
1.3.1 Global Biological Excipient Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biological Excipient Market Size Estimates and Forecasts
1.4.1 Global Biological Excipient Revenue 2020-2031
1.4.2 Global Biological Excipient Sales 2020-2031
1.4.3 Global Biological Excipient Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biological Excipient Market Competition by Manufacturers
2.1 Global Biological Excipient Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biological Excipient Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biological Excipient Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biological Excipient, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biological Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Excipient, Product Type & Application
2.7 Global Key Manufacturers of Biological Excipient, Date of Enter into This Industry
2.8 Global Biological Excipient Market Competitive Situation and Trends
2.8.1 Global Biological Excipient Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biological Excipient Players Market Share by Revenue
2.8.3 Global Biological Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biological Excipient Market Scenario by Region
3.1 Global Biological Excipient Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biological Excipient Sales by Region: 2020-2031
3.2.1 Global Biological Excipient Sales by Region: 2020-2025
3.2.2 Global Biological Excipient Sales by Region: 2026-2031
3.3 Global Biological Excipient Revenue by Region: 2020-2031
3.3.1 Global Biological Excipient Revenue by Region: 2020-2025
3.3.2 Global Biological Excipient Revenue by Region: 2026-2031
3.4 North America Biological Excipient Market Facts & Figures by Country
3.4.1 North America Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biological Excipient Sales by Country (2020-2031)
3.4.3 North America Biological Excipient Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biological Excipient Market Facts & Figures by Country
3.5.1 Europe Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biological Excipient Sales by Country (2020-2031)
3.5.3 Europe Biological Excipient Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Excipient Market Facts & Figures by Region
3.6.1 Asia Pacific Biological Excipient Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biological Excipient Sales by Region (2020-2031)
3.6.3 Asia Pacific Biological Excipient Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biological Excipient Market Facts & Figures by Country
3.7.1 Latin America Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biological Excipient Sales by Country (2020-2031)
3.7.3 Latin America Biological Excipient Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biological Excipient Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biological Excipient Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biological Excipient Sales by Type (2020-2031)
4.1.1 Global Biological Excipient Sales by Type (2020-2025)
4.1.2 Global Biological Excipient Sales by Type (2026-2031)
4.1.3 Global Biological Excipient Sales Market Share by Type (2020-2031)
4.2 Global Biological Excipient Revenue by Type (2020-2031)
4.2.1 Global Biological Excipient Revenue by Type (2020-2025)
4.2.2 Global Biological Excipient Revenue by Type (2026-2031)
4.2.3 Global Biological Excipient Revenue Market Share by Type (2020-2031)
4.3 Global Biological Excipient Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biological Excipient Sales by Application (2020-2031)
5.1.1 Global Biological Excipient Sales by Application (2020-2025)
5.1.2 Global Biological Excipient Sales by Application (2026-2031)
5.1.3 Global Biological Excipient Sales Market Share by Application (2020-2031)
5.2 Global Biological Excipient Revenue by Application (2020-2031)
5.2.1 Global Biological Excipient Revenue by Application (2020-2025)
5.2.2 Global Biological Excipient Revenue by Application (2026-2031)
5.2.3 Global Biological Excipient Revenue Market Share by Application (2020-2031)
5.3 Global Biological Excipient Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ashland Inc.
6.1.1 Ashland Inc. Company Information
6.1.2 Ashland Inc. Description and Business Overview
6.1.3 Ashland Inc. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ashland Inc. Biological Excipient Product Portfolio
6.1.5 Ashland Inc. Recent Developments/Updates
6.2 BASF Corporation
6.2.1 BASF Corporation Company Information
6.2.2 BASF Corporation Description and Business Overview
6.2.3 BASF Corporation Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BASF Corporation Biological Excipient Product Portfolio
6.2.5 BASF Corporation Recent Developments/Updates
6.3 Colorcon Inc.
6.3.1 Colorcon Inc. Company Information
6.3.2 Colorcon Inc. Description and Business Overview
6.3.3 Colorcon Inc. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Colorcon Inc. Biological Excipient Product Portfolio
6.3.5 Colorcon Inc. Recent Developments/Updates
6.4 Evonik Industries
6.4.1 Evonik Industries Company Information
6.4.2 Evonik Industries Description and Business Overview
6.4.3 Evonik Industries Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Evonik Industries Biological Excipient Product Portfolio
6.4.5 Evonik Industries Recent Developments/Updates
6.5 FMC Corporation
6.5.1 FMC Corporation Company Information
6.5.2 FMC Corporation Description and Business Overview
6.5.3 FMC Corporation Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FMC Corporation Biological Excipient Product Portfolio
6.5.5 FMC Corporation Recent Developments/Updates
6.6 The Archer Daniels Midland Company
6.6.1 The Archer Daniels Midland Company Company Information
6.6.2 The Archer Daniels Midland Company Description and Business Overview
6.6.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The Archer Daniels Midland Company Biological Excipient Product Portfolio
6.6.5 The Archer Daniels Midland Company Recent Developments/Updates
6.7 The Dow Chemical Company
6.7.1 The Dow Chemical Company Company Information
6.7.2 The Dow Chemical Company Description and Business Overview
6.7.3 The Dow Chemical Company Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.7.4 The Dow Chemical Company Biological Excipient Product Portfolio
6.7.5 The Dow Chemical Company Recent Developments/Updates
6.8 Wacker Chemie AG.
6.8.1 Wacker Chemie AG. Company Information
6.8.2 Wacker Chemie AG. Description and Business Overview
6.8.3 Wacker Chemie AG. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wacker Chemie AG. Biological Excipient Product Portfolio
6.8.5 Wacker Chemie AG. Recent Developments/Updates
6.9 Merck KGaA
6.9.1 Merck KGaA Company Information
6.9.2 Merck KGaA Description and Business Overview
6.9.3 Merck KGaA Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck KGaA Biological Excipient Product Portfolio
6.9.5 Merck KGaA Recent Developments/Updates
6.10 Colorcon
6.10.1 Colorcon Company Information
6.10.2 Colorcon Description and Business Overview
6.10.3 Colorcon Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Colorcon Biological Excipient Product Portfolio
6.10.5 Colorcon Recent Developments/Updates
6.11 Associated British Foods plc
6.11.1 Associated British Foods plc Company Information
6.11.2 Associated British Foods plc Description and Business Overview
6.11.3 Associated British Foods plc Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Associated British Foods plc Biological Excipient Product Portfolio
6.11.5 Associated British Foods plc Recent Developments/Updates
6.12 Signet Excipients Pvt. Ltd (IMCD)
6.12.1 Signet Excipients Pvt. Ltd (IMCD) Company Information
6.12.2 Signet Excipients Pvt. Ltd (IMCD) Description and Business Overview
6.12.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolio
6.12.5 Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
6.13 Sigachi Industries Limited
6.13.1 Sigachi Industries Limited Company Information
6.13.2 Sigachi Industries Limited Description and Business Overview
6.13.3 Sigachi Industries Limited Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sigachi Industries Limited Biological Excipient Product Portfolio
6.13.5 Sigachi Industries Limited Recent Developments/Updates
6.14 Spectrum Chemical Manufacturing Corp.
6.14.1 Spectrum Chemical Manufacturing Corp. Company Information
6.14.2 Spectrum Chemical Manufacturing Corp. Description and Business Overview
6.14.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolio
6.14.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
6.15 IMCD
6.15.1 IMCD Company Information
6.15.2 IMCD Description and Business Overview
6.15.3 IMCD Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IMCD Biological Excipient Product Portfolio
6.15.5 IMCD Recent Developments/Updates
6.16 Clariant
6.16.1 Clariant Company Information
6.16.2 Clariant Description and Business Overview
6.16.3 Clariant Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Clariant Biological Excipient Product Portfolio
6.16.5 Clariant Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Excipient Industry Chain Analysis
7.2 Biological Excipient Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Excipient Production Mode & Process Analysis
7.4 Biological Excipient Sales and Marketing
7.4.1 Biological Excipient Sales Channels
7.4.2 Biological Excipient Distributors
7.5 Biological Excipient Customer Analysis
8 Biological Excipient Market Dynamics
8.1 Biological Excipient Industry Trends
8.2 Biological Excipient Market Drivers
8.3 Biological Excipient Market Challenges
8.4 Biological Excipient Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Biological Excipient by Type
1.2.1 Global Biological Excipient Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Topical
1.3 Biological Excipient by Application
1.3.1 Global Biological Excipient Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biological Excipient Market Size Estimates and Forecasts
1.4.1 Global Biological Excipient Revenue 2020-2031
1.4.2 Global Biological Excipient Sales 2020-2031
1.4.3 Global Biological Excipient Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biological Excipient Market Competition by Manufacturers
2.1 Global Biological Excipient Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biological Excipient Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biological Excipient Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biological Excipient, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biological Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Excipient, Product Type & Application
2.7 Global Key Manufacturers of Biological Excipient, Date of Enter into This Industry
2.8 Global Biological Excipient Market Competitive Situation and Trends
2.8.1 Global Biological Excipient Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biological Excipient Players Market Share by Revenue
2.8.3 Global Biological Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biological Excipient Market Scenario by Region
3.1 Global Biological Excipient Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biological Excipient Sales by Region: 2020-2031
3.2.1 Global Biological Excipient Sales by Region: 2020-2025
3.2.2 Global Biological Excipient Sales by Region: 2026-2031
3.3 Global Biological Excipient Revenue by Region: 2020-2031
3.3.1 Global Biological Excipient Revenue by Region: 2020-2025
3.3.2 Global Biological Excipient Revenue by Region: 2026-2031
3.4 North America Biological Excipient Market Facts & Figures by Country
3.4.1 North America Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biological Excipient Sales by Country (2020-2031)
3.4.3 North America Biological Excipient Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biological Excipient Market Facts & Figures by Country
3.5.1 Europe Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biological Excipient Sales by Country (2020-2031)
3.5.3 Europe Biological Excipient Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Excipient Market Facts & Figures by Region
3.6.1 Asia Pacific Biological Excipient Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biological Excipient Sales by Region (2020-2031)
3.6.3 Asia Pacific Biological Excipient Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biological Excipient Market Facts & Figures by Country
3.7.1 Latin America Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biological Excipient Sales by Country (2020-2031)
3.7.3 Latin America Biological Excipient Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biological Excipient Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biological Excipient Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biological Excipient Sales by Type (2020-2031)
4.1.1 Global Biological Excipient Sales by Type (2020-2025)
4.1.2 Global Biological Excipient Sales by Type (2026-2031)
4.1.3 Global Biological Excipient Sales Market Share by Type (2020-2031)
4.2 Global Biological Excipient Revenue by Type (2020-2031)
4.2.1 Global Biological Excipient Revenue by Type (2020-2025)
4.2.2 Global Biological Excipient Revenue by Type (2026-2031)
4.2.3 Global Biological Excipient Revenue Market Share by Type (2020-2031)
4.3 Global Biological Excipient Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biological Excipient Sales by Application (2020-2031)
5.1.1 Global Biological Excipient Sales by Application (2020-2025)
5.1.2 Global Biological Excipient Sales by Application (2026-2031)
5.1.3 Global Biological Excipient Sales Market Share by Application (2020-2031)
5.2 Global Biological Excipient Revenue by Application (2020-2031)
5.2.1 Global Biological Excipient Revenue by Application (2020-2025)
5.2.2 Global Biological Excipient Revenue by Application (2026-2031)
5.2.3 Global Biological Excipient Revenue Market Share by Application (2020-2031)
5.3 Global Biological Excipient Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ashland Inc.
6.1.1 Ashland Inc. Company Information
6.1.2 Ashland Inc. Description and Business Overview
6.1.3 Ashland Inc. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ashland Inc. Biological Excipient Product Portfolio
6.1.5 Ashland Inc. Recent Developments/Updates
6.2 BASF Corporation
6.2.1 BASF Corporation Company Information
6.2.2 BASF Corporation Description and Business Overview
6.2.3 BASF Corporation Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BASF Corporation Biological Excipient Product Portfolio
6.2.5 BASF Corporation Recent Developments/Updates
6.3 Colorcon Inc.
6.3.1 Colorcon Inc. Company Information
6.3.2 Colorcon Inc. Description and Business Overview
6.3.3 Colorcon Inc. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Colorcon Inc. Biological Excipient Product Portfolio
6.3.5 Colorcon Inc. Recent Developments/Updates
6.4 Evonik Industries
6.4.1 Evonik Industries Company Information
6.4.2 Evonik Industries Description and Business Overview
6.4.3 Evonik Industries Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Evonik Industries Biological Excipient Product Portfolio
6.4.5 Evonik Industries Recent Developments/Updates
6.5 FMC Corporation
6.5.1 FMC Corporation Company Information
6.5.2 FMC Corporation Description and Business Overview
6.5.3 FMC Corporation Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FMC Corporation Biological Excipient Product Portfolio
6.5.5 FMC Corporation Recent Developments/Updates
6.6 The Archer Daniels Midland Company
6.6.1 The Archer Daniels Midland Company Company Information
6.6.2 The Archer Daniels Midland Company Description and Business Overview
6.6.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The Archer Daniels Midland Company Biological Excipient Product Portfolio
6.6.5 The Archer Daniels Midland Company Recent Developments/Updates
6.7 The Dow Chemical Company
6.7.1 The Dow Chemical Company Company Information
6.7.2 The Dow Chemical Company Description and Business Overview
6.7.3 The Dow Chemical Company Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.7.4 The Dow Chemical Company Biological Excipient Product Portfolio
6.7.5 The Dow Chemical Company Recent Developments/Updates
6.8 Wacker Chemie AG.
6.8.1 Wacker Chemie AG. Company Information
6.8.2 Wacker Chemie AG. Description and Business Overview
6.8.3 Wacker Chemie AG. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wacker Chemie AG. Biological Excipient Product Portfolio
6.8.5 Wacker Chemie AG. Recent Developments/Updates
6.9 Merck KGaA
6.9.1 Merck KGaA Company Information
6.9.2 Merck KGaA Description and Business Overview
6.9.3 Merck KGaA Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck KGaA Biological Excipient Product Portfolio
6.9.5 Merck KGaA Recent Developments/Updates
6.10 Colorcon
6.10.1 Colorcon Company Information
6.10.2 Colorcon Description and Business Overview
6.10.3 Colorcon Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Colorcon Biological Excipient Product Portfolio
6.10.5 Colorcon Recent Developments/Updates
6.11 Associated British Foods plc
6.11.1 Associated British Foods plc Company Information
6.11.2 Associated British Foods plc Description and Business Overview
6.11.3 Associated British Foods plc Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Associated British Foods plc Biological Excipient Product Portfolio
6.11.5 Associated British Foods plc Recent Developments/Updates
6.12 Signet Excipients Pvt. Ltd (IMCD)
6.12.1 Signet Excipients Pvt. Ltd (IMCD) Company Information
6.12.2 Signet Excipients Pvt. Ltd (IMCD) Description and Business Overview
6.12.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolio
6.12.5 Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
6.13 Sigachi Industries Limited
6.13.1 Sigachi Industries Limited Company Information
6.13.2 Sigachi Industries Limited Description and Business Overview
6.13.3 Sigachi Industries Limited Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sigachi Industries Limited Biological Excipient Product Portfolio
6.13.5 Sigachi Industries Limited Recent Developments/Updates
6.14 Spectrum Chemical Manufacturing Corp.
6.14.1 Spectrum Chemical Manufacturing Corp. Company Information
6.14.2 Spectrum Chemical Manufacturing Corp. Description and Business Overview
6.14.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolio
6.14.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
6.15 IMCD
6.15.1 IMCD Company Information
6.15.2 IMCD Description and Business Overview
6.15.3 IMCD Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IMCD Biological Excipient Product Portfolio
6.15.5 IMCD Recent Developments/Updates
6.16 Clariant
6.16.1 Clariant Company Information
6.16.2 Clariant Description and Business Overview
6.16.3 Clariant Biological Excipient Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Clariant Biological Excipient Product Portfolio
6.16.5 Clariant Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Excipient Industry Chain Analysis
7.2 Biological Excipient Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Excipient Production Mode & Process Analysis
7.4 Biological Excipient Sales and Marketing
7.4.1 Biological Excipient Sales Channels
7.4.2 Biological Excipient Distributors
7.5 Biological Excipient Customer Analysis
8 Biological Excipient Market Dynamics
8.1 Biological Excipient Industry Trends
8.2 Biological Excipient Market Drivers
8.3 Biological Excipient Market Challenges
8.4 Biological Excipient Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Biological Excipient Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Biological Excipient Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Biological Excipient Market Competitive Situation by Manufacturers in 2024
Table 4. Global Biological Excipient Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Biological Excipient Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Biological Excipient Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Biological Excipient Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Biological Excipient Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Biological Excipient, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biological Excipient, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biological Excipient, Product Type & Application
Table 12. Global Key Manufacturers of Biological Excipient, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biological Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Excipient as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biological Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Biological Excipient Sales by Region (2020-2025) & (K Units)
Table 18. Global Biological Excipient Sales Market Share by Region (2020-2025)
Table 19. Global Biological Excipient Sales by Region (2026-2031) & (K Units)
Table 20. Global Biological Excipient Sales Market Share by Region (2026-2031)
Table 21. Global Biological Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Biological Excipient Revenue Market Share by Region (2020-2025)
Table 23. Global Biological Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Biological Excipient Revenue Market Share by Region (2026-2031)
Table 25. North America Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 27. North America Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 28. North America Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 32. Europe Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 33. Europe Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Biological Excipient Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Biological Excipient Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Biological Excipient Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Biological Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Biological Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Biological Excipient Sales (K Units) by Type (2020-2025)
Table 51. Global Biological Excipient Sales (K Units) by Type (2026-2031)
Table 52. Global Biological Excipient Sales Market Share by Type (2020-2025)
Table 53. Global Biological Excipient Sales Market Share by Type (2026-2031)
Table 54. Global Biological Excipient Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Biological Excipient Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Biological Excipient Revenue Market Share by Type (2020-2025)
Table 57. Global Biological Excipient Revenue Market Share by Type (2026-2031)
Table 58. Global Biological Excipient Price (US$/Unit) by Type (2020-2025)
Table 59. Global Biological Excipient Price (US$/Unit) by Type (2026-2031)
Table 60. Global Biological Excipient Sales (K Units) by Application (2020-2025)
Table 61. Global Biological Excipient Sales (K Units) by Application (2026-2031)
Table 62. Global Biological Excipient Sales Market Share by Application (2020-2025)
Table 63. Global Biological Excipient Sales Market Share by Application (2026-2031)
Table 64. Global Biological Excipient Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Biological Excipient Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Biological Excipient Revenue Market Share by Application (2020-2025)
Table 67. Global Biological Excipient Revenue Market Share by Application (2026-2031)
Table 68. Global Biological Excipient Price (US$/Unit) by Application (2020-2025)
Table 69. Global Biological Excipient Price (US$/Unit) by Application (2026-2031)
Table 70. Ashland Inc. Company Information
Table 71. Ashland Inc. Description and Business Overview
Table 72. Ashland Inc. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Ashland Inc. Biological Excipient Product
Table 74. Ashland Inc. Recent Developments/Updates
Table 75. BASF Corporation Company Information
Table 76. BASF Corporation Description and Business Overview
Table 77. BASF Corporation Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BASF Corporation Biological Excipient Product
Table 79. BASF Corporation Recent Developments/Updates
Table 80. Colorcon Inc. Company Information
Table 81. Colorcon Inc. Description and Business Overview
Table 82. Colorcon Inc. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Colorcon Inc. Biological Excipient Product
Table 84. Colorcon Inc. Recent Developments/Updates
Table 85. Evonik Industries Company Information
Table 86. Evonik Industries Description and Business Overview
Table 87. Evonik Industries Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Evonik Industries Biological Excipient Product
Table 89. Evonik Industries Recent Developments/Updates
Table 90. FMC Corporation Company Information
Table 91. FMC Corporation Description and Business Overview
Table 92. FMC Corporation Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. FMC Corporation Biological Excipient Product
Table 94. FMC Corporation Recent Developments/Updates
Table 95. The Archer Daniels Midland Company Company Information
Table 96. The Archer Daniels Midland Company Description and Business Overview
Table 97. The Archer Daniels Midland Company Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. The Archer Daniels Midland Company Biological Excipient Product
Table 99. The Archer Daniels Midland Company Recent Developments/Updates
Table 100. The Dow Chemical Company Company Information
Table 101. The Dow Chemical Company Description and Business Overview
Table 102. The Dow Chemical Company Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. The Dow Chemical Company Biological Excipient Product
Table 104. The Dow Chemical Company Recent Developments/Updates
Table 105. Wacker Chemie AG. Company Information
Table 106. Wacker Chemie AG. Description and Business Overview
Table 107. Wacker Chemie AG. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Wacker Chemie AG. Biological Excipient Product
Table 109. Wacker Chemie AG. Recent Developments/Updates
Table 110. Merck KGaA Company Information
Table 111. Merck KGaA Description and Business Overview
Table 112. Merck KGaA Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Merck KGaA Biological Excipient Product
Table 114. Merck KGaA Recent Developments/Updates
Table 115. Colorcon Company Information
Table 116. Colorcon Description and Business Overview
Table 117. Colorcon Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Colorcon Biological Excipient Product
Table 119. Colorcon Recent Developments/Updates
Table 120. Associated British Foods plc Company Information
Table 121. Associated British Foods plc Description and Business Overview
Table 122. Associated British Foods plc Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Associated British Foods plc Biological Excipient Product
Table 124. Associated British Foods plc Recent Developments/Updates
Table 125. Signet Excipients Pvt. Ltd (IMCD) Company Information
Table 126. Signet Excipients Pvt. Ltd (IMCD) Description and Business Overview
Table 127. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product
Table 129. Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
Table 130. Sigachi Industries Limited Company Information
Table 131. Sigachi Industries Limited Description and Business Overview
Table 132. Sigachi Industries Limited Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sigachi Industries Limited Biological Excipient Product
Table 134. Sigachi Industries Limited Recent Developments/Updates
Table 135. Spectrum Chemical Manufacturing Corp. Company Information
Table 136. Spectrum Chemical Manufacturing Corp. Description and Business Overview
Table 137. Spectrum Chemical Manufacturing Corp. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Spectrum Chemical Manufacturing Corp. Biological Excipient Product
Table 139. Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
Table 140. IMCD Company Information
Table 141. IMCD Description and Business Overview
Table 142. IMCD Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. IMCD Biological Excipient Product
Table 144. IMCD Recent Developments/Updates
Table 145. Clariant Company Information
Table 146. Clariant Description and Business Overview
Table 147. Clariant Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Clariant Biological Excipient Product
Table 149. Clariant Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Biological Excipient Distributors List
Table 153. Biological Excipient Customers List
Table 154. Biological Excipient Market Trends
Table 155. Biological Excipient Market Drivers
Table 156. Biological Excipient Market Challenges
Table 157. Biological Excipient Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biological Excipient
Figure 2. Global Biological Excipient Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biological Excipient Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Biological Excipient Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Biological Excipient Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Biological Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biological Excipient Market Size (2020-2031) & (US$ Million)
Figure 13. Global Biological Excipient Sales (2020-2031) & (K Units)
Figure 14. Global Biological Excipient Average Price (US$/Unit) & (2020-2031)
Figure 15. Biological Excipient Report Years Considered
Figure 16. Biological Excipient Sales Share by Manufacturers in 2024
Figure 17. Global Biological Excipient Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Biological Excipient Players: Market Share by Revenue in Biological Excipient in 2024
Figure 19. Biological Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Biological Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Biological Excipient Sales Market Share by Country (2020-2031)
Figure 22. North America Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 23. United States Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Biological Excipient Sales Market Share by Country (2020-2031)
Figure 26. Europe Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 27. Germany Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Biological Excipient Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Biological Excipient Revenue Market Share by Region (2020-2031)
Figure 34. China Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Biological Excipient Sales Market Share by Country (2020-2031)
Figure 44. Latin America Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Biological Excipient Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Biological Excipient by Type (2020-2031)
Figure 54. Global Revenue Market Share of Biological Excipient by Type (2020-2031)
Figure 55. Global Biological Excipient Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Biological Excipient by Application (2020-2031)
Figure 57. Global Revenue Market Share of Biological Excipient by Application (2020-2031)
Figure 58. Global Biological Excipient Price (US$/Unit) by Application (2020-2031)
Figure 59. Biological Excipient Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Biological Excipient Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Biological Excipient Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Biological Excipient Market Competitive Situation by Manufacturers in 2024
Table 4. Global Biological Excipient Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Biological Excipient Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Biological Excipient Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Biological Excipient Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Biological Excipient Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Biological Excipient, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biological Excipient, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biological Excipient, Product Type & Application
Table 12. Global Key Manufacturers of Biological Excipient, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biological Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Excipient as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biological Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Biological Excipient Sales by Region (2020-2025) & (K Units)
Table 18. Global Biological Excipient Sales Market Share by Region (2020-2025)
Table 19. Global Biological Excipient Sales by Region (2026-2031) & (K Units)
Table 20. Global Biological Excipient Sales Market Share by Region (2026-2031)
Table 21. Global Biological Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Biological Excipient Revenue Market Share by Region (2020-2025)
Table 23. Global Biological Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Biological Excipient Revenue Market Share by Region (2026-2031)
Table 25. North America Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 27. North America Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 28. North America Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 32. Europe Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 33. Europe Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Biological Excipient Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Biological Excipient Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Biological Excipient Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Biological Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Biological Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Biological Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Biological Excipient Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Biological Excipient Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Biological Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Biological Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Biological Excipient Sales (K Units) by Type (2020-2025)
Table 51. Global Biological Excipient Sales (K Units) by Type (2026-2031)
Table 52. Global Biological Excipient Sales Market Share by Type (2020-2025)
Table 53. Global Biological Excipient Sales Market Share by Type (2026-2031)
Table 54. Global Biological Excipient Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Biological Excipient Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Biological Excipient Revenue Market Share by Type (2020-2025)
Table 57. Global Biological Excipient Revenue Market Share by Type (2026-2031)
Table 58. Global Biological Excipient Price (US$/Unit) by Type (2020-2025)
Table 59. Global Biological Excipient Price (US$/Unit) by Type (2026-2031)
Table 60. Global Biological Excipient Sales (K Units) by Application (2020-2025)
Table 61. Global Biological Excipient Sales (K Units) by Application (2026-2031)
Table 62. Global Biological Excipient Sales Market Share by Application (2020-2025)
Table 63. Global Biological Excipient Sales Market Share by Application (2026-2031)
Table 64. Global Biological Excipient Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Biological Excipient Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Biological Excipient Revenue Market Share by Application (2020-2025)
Table 67. Global Biological Excipient Revenue Market Share by Application (2026-2031)
Table 68. Global Biological Excipient Price (US$/Unit) by Application (2020-2025)
Table 69. Global Biological Excipient Price (US$/Unit) by Application (2026-2031)
Table 70. Ashland Inc. Company Information
Table 71. Ashland Inc. Description and Business Overview
Table 72. Ashland Inc. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Ashland Inc. Biological Excipient Product
Table 74. Ashland Inc. Recent Developments/Updates
Table 75. BASF Corporation Company Information
Table 76. BASF Corporation Description and Business Overview
Table 77. BASF Corporation Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BASF Corporation Biological Excipient Product
Table 79. BASF Corporation Recent Developments/Updates
Table 80. Colorcon Inc. Company Information
Table 81. Colorcon Inc. Description and Business Overview
Table 82. Colorcon Inc. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Colorcon Inc. Biological Excipient Product
Table 84. Colorcon Inc. Recent Developments/Updates
Table 85. Evonik Industries Company Information
Table 86. Evonik Industries Description and Business Overview
Table 87. Evonik Industries Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Evonik Industries Biological Excipient Product
Table 89. Evonik Industries Recent Developments/Updates
Table 90. FMC Corporation Company Information
Table 91. FMC Corporation Description and Business Overview
Table 92. FMC Corporation Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. FMC Corporation Biological Excipient Product
Table 94. FMC Corporation Recent Developments/Updates
Table 95. The Archer Daniels Midland Company Company Information
Table 96. The Archer Daniels Midland Company Description and Business Overview
Table 97. The Archer Daniels Midland Company Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. The Archer Daniels Midland Company Biological Excipient Product
Table 99. The Archer Daniels Midland Company Recent Developments/Updates
Table 100. The Dow Chemical Company Company Information
Table 101. The Dow Chemical Company Description and Business Overview
Table 102. The Dow Chemical Company Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. The Dow Chemical Company Biological Excipient Product
Table 104. The Dow Chemical Company Recent Developments/Updates
Table 105. Wacker Chemie AG. Company Information
Table 106. Wacker Chemie AG. Description and Business Overview
Table 107. Wacker Chemie AG. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Wacker Chemie AG. Biological Excipient Product
Table 109. Wacker Chemie AG. Recent Developments/Updates
Table 110. Merck KGaA Company Information
Table 111. Merck KGaA Description and Business Overview
Table 112. Merck KGaA Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Merck KGaA Biological Excipient Product
Table 114. Merck KGaA Recent Developments/Updates
Table 115. Colorcon Company Information
Table 116. Colorcon Description and Business Overview
Table 117. Colorcon Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Colorcon Biological Excipient Product
Table 119. Colorcon Recent Developments/Updates
Table 120. Associated British Foods plc Company Information
Table 121. Associated British Foods plc Description and Business Overview
Table 122. Associated British Foods plc Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Associated British Foods plc Biological Excipient Product
Table 124. Associated British Foods plc Recent Developments/Updates
Table 125. Signet Excipients Pvt. Ltd (IMCD) Company Information
Table 126. Signet Excipients Pvt. Ltd (IMCD) Description and Business Overview
Table 127. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product
Table 129. Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
Table 130. Sigachi Industries Limited Company Information
Table 131. Sigachi Industries Limited Description and Business Overview
Table 132. Sigachi Industries Limited Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sigachi Industries Limited Biological Excipient Product
Table 134. Sigachi Industries Limited Recent Developments/Updates
Table 135. Spectrum Chemical Manufacturing Corp. Company Information
Table 136. Spectrum Chemical Manufacturing Corp. Description and Business Overview
Table 137. Spectrum Chemical Manufacturing Corp. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Spectrum Chemical Manufacturing Corp. Biological Excipient Product
Table 139. Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
Table 140. IMCD Company Information
Table 141. IMCD Description and Business Overview
Table 142. IMCD Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. IMCD Biological Excipient Product
Table 144. IMCD Recent Developments/Updates
Table 145. Clariant Company Information
Table 146. Clariant Description and Business Overview
Table 147. Clariant Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Clariant Biological Excipient Product
Table 149. Clariant Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Biological Excipient Distributors List
Table 153. Biological Excipient Customers List
Table 154. Biological Excipient Market Trends
Table 155. Biological Excipient Market Drivers
Table 156. Biological Excipient Market Challenges
Table 157. Biological Excipient Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biological Excipient
Figure 2. Global Biological Excipient Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biological Excipient Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Biological Excipient Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Biological Excipient Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Biological Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biological Excipient Market Size (2020-2031) & (US$ Million)
Figure 13. Global Biological Excipient Sales (2020-2031) & (K Units)
Figure 14. Global Biological Excipient Average Price (US$/Unit) & (2020-2031)
Figure 15. Biological Excipient Report Years Considered
Figure 16. Biological Excipient Sales Share by Manufacturers in 2024
Figure 17. Global Biological Excipient Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Biological Excipient Players: Market Share by Revenue in Biological Excipient in 2024
Figure 19. Biological Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Biological Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Biological Excipient Sales Market Share by Country (2020-2031)
Figure 22. North America Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 23. United States Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Biological Excipient Sales Market Share by Country (2020-2031)
Figure 26. Europe Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 27. Germany Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Biological Excipient Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Biological Excipient Revenue Market Share by Region (2020-2031)
Figure 34. China Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Biological Excipient Sales Market Share by Country (2020-2031)
Figure 44. Latin America Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Biological Excipient Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Biological Excipient Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Biological Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Biological Excipient by Type (2020-2031)
Figure 54. Global Revenue Market Share of Biological Excipient by Type (2020-2031)
Figure 55. Global Biological Excipient Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Biological Excipient by Application (2020-2031)
Figure 57. Global Revenue Market Share of Biological Excipient by Application (2020-2031)
Figure 58. Global Biological Excipient Price (US$/Unit) by Application (2020-2031)
Figure 59. Biological Excipient Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232